Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
  • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
  • C07D471/04—Ortho-condensed systems
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
  • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
  • A61P31/12—Antivirals
  • A61P31/14—Antivirals for RNA viruses
  • A61P31/18—Antivirals for RNA viruses for HIV
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
  • C07F9/02—Phosphorus compounds
  • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
  • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Veterinary Medicine (AREA)
• Molecular Biology (AREA)
• Public Health (AREA)
• Animal Behavior & Ethology (AREA)
• Pharmacology & Pharmacy (AREA)
• Biochemistry (AREA)
• Virology (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Communicable Diseases (AREA)
• Tropical Medicine & Parasitology (AREA)
• Engineering & Computer Science (AREA)
• Oncology (AREA)
• AIDS & HIV (AREA)
• Epidemiology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=45688987

Family Applications (1)

Country Status (25)

Families Citing this family (9)

Family Cites Families (5)

• 2012
  • 2012-01-27 PT PT127049609T patent/PT2670751E/pt unknown
  • 2012-01-27 DK DK12704960.9T patent/DK2670751T3/en active
  • 2012-01-27 EP EP20120704960 patent/EP2670751B1/en active Active
  • 2012-01-27 US US13/359,708 patent/US8436168B2/en active Active
  • 2012-01-27 SI SI201230225T patent/SI2670751T1/sl unknown
  • 2012-01-27 KR KR1020137022709A patent/KR101848533B1/ko not_active Expired - Fee Related
  • 2012-01-27 CA CA2826260A patent/CA2826260C/en not_active Expired - Fee Related
  • 2012-01-27 AU AU2012212508A patent/AU2012212508B2/en not_active Ceased
  • 2012-01-27 CN CN201280007153.8A patent/CN103339130B/zh not_active Expired - Fee Related
  • 2012-01-27 MX MX2013008371A patent/MX2013008371A/es active IP Right Grant
  • 2012-01-27 HU HUE12704960A patent/HUE026880T2/en unknown
  • 2012-01-27 SG SG2013051560A patent/SG191841A1/en unknown
  • 2012-01-27 RS RS20150388A patent/RS54055B1/sr unknown
  • 2012-01-27 JP JP2013551361A patent/JP6006236B2/ja active Active
  • 2012-01-27 PL PL12704960T patent/PL2670751T3/pl unknown
  • 2012-01-27 ES ES12704960.9T patent/ES2539908T3/es active Active
  • 2012-01-27 BR BR112013018159A patent/BR112013018159A2/pt not_active Application Discontinuation
  • 2012-01-27 EA EA201391123A patent/EA021726B1/ru not_active IP Right Cessation
  • 2012-01-27 WO PCT/US2012/022851 patent/WO2012106189A1/en not_active Ceased
  • 2012-01-27 HR HRP20150616TT patent/HRP20150616T1/hr unknown
  • 2012-01-31 TW TW101103123A patent/TW201309692A/zh unknown
  • 2012-01-31 AR ARP120100313A patent/AR085052A1/es not_active Application Discontinuation
• 2013
  • 2013-07-02 IL IL227302A patent/IL227302A/en active IP Right Grant
• 2015
  • 2015-07-14 SM SM201500169T patent/SMT201500169B/xx unknown
  • 2015-07-17 CY CY20151100631T patent/CY1116505T1/el unknown

Also Published As

Similar Documents